Connect with us

Technology

FlowerAura Introduces a Secure and User-Friendly Way to Send Video Messages with Gifts

Published

on

GURUGRAM, India, May 5, 2023 /PRNewswire/ — FlowerAura, India’s online gifting giant, has introduced Hippo Video, a new feature allowing users to send personalized video messages and gifts.

 

Hippo Video offers a simple and user-friendly interface that makes recording and sending video messages easy. Users can record their messages on the payment confirmation page, track order page, or my order page, adding an extra touch of emotion and personality to their gifts.

In a media conversation, Mr Shrey Sehgal, Co-founder of FlowerAura said,”We’re excited to bring this innovative feature to our users, and we hope it helps them connect with their loved ones in new and meaningful ways. The joy of receiving a gift increases to many fold when there are special video messages from the sender. The excitement of knowing what the gifter has to say is what makes this feature a top-notch in uplifting the whole experience. As an online gift portal, we are en-route to the highest customer satisfaction and unforgettable experience; this newly launched feature is part of that journey.

But that’s not all. Hippo Video is also secure and private. It uses end-to-end encryption and OTP verification to ensure that only the intended recipient can view the video message. A QR code is printed on the message card that the recipient can scan to access the video, and they will need to enter their details and receive an OTP on their mobile number before they can view it. Recipients will also receive video links on SMS and WhatsApp.

With its user-friendly interface and integration, Hippo Video makes sending video messages with gifts easy and convenient. Hippo Video is an innovative and personalized way to convey your emotions to the fullest and send them along with gifts. FlowerAura is quite positive about the upcoming response from the customers and firmly believes that this feature will give more to both the gifter and the receiver. 

About FA Gifts Pvt. Ltd.

FA Gifts Pvt. Ltd. (FlowerAura), a pioneer of the gift industry, has flourished in the Indian & International market with its gift range (flowers, cakes, indoor plants, decor items, personalized gifts, combos) for the special moments that can’t be put into words. Starting in 2010, under the entrepreneurship of Mr Himanshu Chawla and Mr Shrey Sehgal, the company launched its first FlowerAura store in the city of Gurgaon. Today, we lead the gifting market in more than 600+ cities to deliver a delightful experience for every customer out there.

Video:  https://www.youtube.com/shorts/AK2D2chaCk8
Logo: https://mma.prnewswire.com/media/1832283/Floweraura_Logo.jpg

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/floweraura-introduces-a-secure-and-user-friendly-way-to-send-video-messages-with-gifts-301816296.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Science and Technology Daily: Global Talents Enjoy the Honor of China

Published

on

By

BEIJING, June 23, 2024 /PRNewswire/ — It’s a tremendous honor to receive the China International Science and Technology Cooperation Award. We pay high tribute to those honorees who have made important contributions to scientific and technological advancements. Let’s look forward to seeing who will be awarded this honor this year.

View original content to download multimedia:https://www.prnewswire.com/news-releases/science-and-technology-daily-global-talents-enjoy-the-honor-of-china-302179675.html

SOURCE Science and Technology Daily

Continue Reading

Technology

Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa

Published

on

By

SINGAPORE, June 23, 2024 /PRNewswire/ — Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)’ solid tumour molecular profiling services in the Middle East and Africa (MEA). Caris is the leading next-generation AI TechBio company and precision medicine pioneer. This expansion follows the initial January 2023 distribution rights partnership with Caris for the same services in Southeast Asia (SEA). Juniper is now poised to offer Caris’ advanced solid tumour molecular profiling services across a broader region, enhancing patient access to personalised treatment options.

Caris’ best-in-class molecular profiling, combined with proprietary artificial intelligence, provides more precise and individualized cancer treatments. This profiling approach assesses DNA, RNA, and proteins, revealing a molecular blueprint that identifies treatment options specific to each patient’s cancer. Caris has developed the world’s largest and most informative platform for cancer analysis, featuring the most advanced tumour profiling available, including Whole Exome and Whole Transcriptome Sequencing across over 23,000 genes. By analysing biomarkers found in tumours, Caris helps healthcare providers make informed choices for personalised care.

Juniper Biologics is committed to driving positive change in the pharmaceutical industry on a global scale. Aligned with its mission to deliver transformative therapies through bold scientific innovation, Juniper’s collaboration with Caris will enhance access to quality treatments for patient communities in the Middle East and Africa. Juniper continues to pursue impactful partnerships aimed at uplifting communities and individuals, especially in underserved regions where access to advanced therapies is limited.

Raman Singh, Founder and Chief Executive Officer (CEO) of Juniper Biologics, spoke on the successful acquisition: “Caris molecular profiling bridges the gap between tumour biology and cancer treatments, guiding precision medicine through personalised treatment selection for physicians and their patients. Our exclusive partnership with Caris Life Sciences to distribute this service in the Middle East and Africa will significantly empower healthcare professionals to make informed decisions for their patients. This service enables oncologists to recommend highly personalised treatments that specifically target a patient’s cancer, thereby improving and expanding their care options. This targeted approach offers patients, particularly those with rare or aggressive cancers, an improved quality of life.”

“Caris is pleased to expand the distribution of our molecular profiling services in the Middle East and Africa through our partnership with Juniper Biologics,” said Caris President David Spetzler, MS, PhD, MBA. “This collaboration aligns with Caris’ goal of enabling clinicians worldwide to make the best individualised treatment choices for their patients and ultimately helping to improve patient outcomes.”

This partnership marks a significant milestone in expanding access to personalised medicine and advanced cancer treatment technologies in the Middle East and Africa.

About Juniper Biologics

Backed by The Sylvan Group, Juniper Biologics is a science-led healthcare company focused on delivering novel therapies to improve the health and quality of life of patients, by building a growing presence in Oncology and Oncology Supportive Care, Rare/Orphan Diseases and Gene Therapy. It was founded on a vision to provide treatments for unmet medical needs focused on specialist therapy areas in which it can make the most difference. Through bold and transformative science, Juniper Biologics is committed to creating possibilities that have the potential to become the next generation of life-changing medicines for patient communities in China, Japan, Asia, Australia, New Zealand, Middle East, and Africa.

Website: https://www.juniperbiologics.com/

LinkedIn: https://www.linkedin.com/company/juniper-biologics

About Caris Life Sciences
Caris Life Sciences® (Caris) is the leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms, Caris has created the large-scale, multi-modal database and computing capability needed to analyse and unravel the molecular complexity of disease. This convergence of sequencing power, big data, and AI technologies provides an unmatched platform to deliver the next generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection, and drug development.

Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia, and other international markets. To learn more, please visit CarisLifeSciences.com.

 

View original content:https://www.prnewswire.co.uk/news-releases/juniper-biologics-expands-distribution-rights-for-caris-life-sciences-molecular-profiling-in-the-middle-east-and-africa-302179643.html

Continue Reading

Technology

Rīgas Satiksme (Riga municipality public transportation) achieves significant cost and carbon savings with Papercast e-paper

Published

on

By

Rīgas Satiksme is further enhancing the travel experience for Riga’s Public transport users with the second phase rollout of Papercast® sustainable, low power e-paper displays. This initiative underscores Rīgas municipality owned Public transportation company shift from traditional, power-hungry LED displays to more sustainable technologies.

LONDON and RIGA, Latvia, June 23, 2024 /PRNewswire-PRWeb/ — Rīgas Satiksme is further enhancing the travel experience for Riga’s Public transport users with the second phase rollout of Papercast® sustainable, low power e-paper displays. This initiative underscores Rīgas municipality owned Public transportation company shift from traditional, power-hungry LED displays to more sustainable technologies.

“We are thrilled to continue our partnership with Rīgas Satiksme in their mission to embrace cutting edge, sustainable passenger information solutions,” said Cameron Maconie, Head of Business Development at Papercast.

Driven by the success of its initial deployment and buoyed by positive feedback from passengers, Rīgas Satiksme is extending its digitalization of public transport stops network with Papercast’s 23″ e-paper displays. Following a rigorous evaluation process, Rīgas selected Papercast for this second phase expansion, highlighting the calibre and sustainability of its technology.

Maximising cost and carbon savings

Offering one of the most sustainable digital bus stop solutions available, the Papercast displays supplied to Rīgas Satiksme recharge overnight using streetlight power, ensuring minimal energy consumption and high functionality. This setup enables significant cost and carbon savings:

Papercast e-paper displays use only 15 Wh per day, compared to 1,080 Wh for LED displays—a remarkable 98.6% reduction.This translates to an annual cost of €1.53 per display for Papercast, compared to €1,080 for LED.Papercast’s displays emit just 1 kg carbon annually compared to 82 kg for LED—a 98.8% decrease.

These savings are crucial for Rīgas Satiksme as they move towards more sustainable public transport solutions as add on to the new Electrical bus fleet and Trams lines extension .

Retrofitting for efficiency

The decision to expand the network with Papercast’s e-paper displays is rooted in their stability, excellent outdoor visibility, user-friendly interface, low power consumption, ease of installation and customisable features. By retrofitting the displays onto Rīgas’ Satiksme existing infrastructure, deployment time and costs are minimised, including integration with new fleet management system.

Enhanced passenger experience

The 23″ e-paper displays provide real-time information at digital stops and shelters for trams, buses and trolleybus services. The content management system (CMS) allows for effortless control over content dissemination and device management, enhancing the overall proposition.

“We are thrilled to continue our partnership with Rīgas Satiksme in their mission to embrace cutting edge, sustainable passenger information solutions,” said Cameron Maconie, Head of Business Development at Papercast. “The selection of Papercast displays for the second phase rollout underscores the unmatched benefits of our market leading technology, making it the ideal choice for modernising public transport infrastructure.”

Using E Ink technology, Papercast e-paper bus stop displays are well proven around the world with deployments in more than 45 countries.

ABOUT PAPERCAST

Papercast’s range of solar powered, wireless e-paper bus stop displays provide excellent visibility, even in direct sunlight, and have been engineered with leading design principles of superior functionality and exceptionally low energy consumption. Completely stand-alone, the displays can be easily installed ‘off-the-grid’ within hours and the cloud-based data management platform provides complete control and real-time data integration.

www.papercast.com

Share this story and follow Papercast on Twitter, LinkedIn, Facebook and YouTube

CONTACT INFORMATION

Kerry Marchbank

Marketing Manager

+44 (0)7817 916654

kmarchbank@papercast.com

Media Contact

Kerry Marchbank, Papercast Ltd, 44 02070431355, kmarchbank@papercast.com, www.papercast.com

View original content to download multimedia:https://www.prweb.com/releases/rgas-satiksme-riga-municipality-public-transportation-achieves-significant-cost-and-carbon-savings-with-papercast-e-paper-302179188.html

SOURCE Papercast Ltd

Continue Reading

Trending